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Review

Obsessive–compulsive disorder in the
postpartum period: diagnosis, differential
diagnosis and management

Childbirth can trigger or exacerbate a variety of psychiatric disorders but the extant
literature has focused primarily on mood disorders. Obsessive–compulsive disorder
(OCD) after childbirth can occur alone or in combination with other psychiatric
disorders such as major depressive disorder. Due to the general lack of awareness of
the relationship between childbirth and OCD among clinicians as well as patients, the
disorder may be underdiagnosed or misdiagnosed as major depressive disorder. This
article describes the prevalence, clinical features, common psychiatric comorbidities,
differential diagnosis and potential consequences of underdiagnosis or misdiagnosis.
Using case vignettes strategies for its detection and clinical management are
suggested. Finally, areas in need of further research are proposed.
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Clinical vignettes
‘Ms A’ is a 25-year-old married woman who
is referred for a psychiatric assessment with
a history of recurrent thoughts and images
of stabbing her child since her first delivery
4 weeks earlier. She is afraid to be left alone
with the baby and worries that she may accidentally harm the newborn. She has asked
her husband to hide the kitchen knives and
sharp objects. She is aware of the senseless
nature of the thoughts and tries to avoid
them but feels unable to do so. She finds the
thoughts highly distressing but denies any
current symptoms of depression. She had
a major depressive episode 5 years ago that
was treated with fluvoxamine 150 mg daily.
Family history is positive for major depressive
disorder.
‘Ms B’ is a 27-year-old married woman
who is referred by her family physician with
a suspected diagnosis of postpartum psychosis. Within days of delivering her first child,
she started having recurrent and persistent
thoughts that her father had inappropriately touched the newborn. She shared these
thoughts with her husband and both agreed
that there was no basis for her concerns.
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However, over the next couple of weeks,
she became increasingly convinced that her
father had sexually abused the newborn. She
reported the matter to child protection services who thoroughly investigated and concluded the allegations were false. Apart from
having the delusional belief about sexual
abuse there were no psychotic features. Also,
there were no concomitant symptoms of
depression or mania. She had been treated for
obsessive–compulsive disorder with sertraline in the past but had stopped the medication in anticipation of pregnancy. There is no
known family history of psychiatric illness.
The Diagnostic and Statistical Manual of
Mental Disorders, Fifth Edition (DSM-5)
defines
obsessive–compulsive
disorder
(OCD) as the presence of obsessions, compulsions or both that are time consuming
(for example, take more than 1 h per day) or
cause significant distress or impairment in
social, occupational or other important areas
of functioning [1] (see Box 1 for the diagnostic criteria and definitions of obsessions and
compulsions). DSM-5 allows the specification of OCD along a spectrum with individuals at the severe end having absent insight or
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Box 1. DSM-5 diagnostic criteria for obsessive–compulsive disorder.
• Presence of obsessions, compulsions or both:
–– Obsessions are defined by:
–– Recurrent and persistent thoughts, urges or images that are experienced at some time during the
disturbance, as intrusive and unwanted, and that in most individuals cause marked anxiety or distress
–– The individual attempts to ignore or suppress such thoughts, urges or images or to neutralize them with
some other thought or action
–– Compulsions are defined by:
–– Repetitive behaviors or mental acts that the individual feels driven to perform in response to an
obsession or according to rules that must be applied rigidly
–– The behaviors or mental acts are aimed at preventing or reducing anxiety or distress, or preventing some
dreaded event or situation; however, these behaviors or mental acts are not connected in a realistic way
with what they are designed to neutralize or prevent, or are clearly excessive
• The obsessions or compulsions are time consuming (e.g., take more than 1 h a day) or cause clinically
significant distress or impairment in social, occupational or other important areas of functioning
• The obsessive–compulsive symptoms are not attributable to the physiological effects of a substance (e.g., a
drug of abuse, a medication) or another medical condition
• The disturbance is not better explained by the symptoms of another mental disorder

delusional beliefs. Unlike the DSM-IV-TR [2] , OCD
has its own chapter (obsessive–compulsive and related
disorders) in DSM-5 and is no longer considered an
anxiety disorder.
OCD symptoms usually begin during childhood
or adolescence but the average age at illness onset is
19.5 years [3] . OCD is more common among women,
however, the gender difference in the prevalence of
OCD is smaller compared with mood and anxiety
disorders [3] . Gender differences also exist in the onset
and course of OCD. For example, women are affected
at a slightly higher rate than men in adulthood and
women are also more likely to have symptoms in the
cleaning dimension and greater comorbidity with eating and impulse-control disorders [4,5] . OCD tends to
cluster during the childbearing years partly due to the
triggering role of reproductive events especially menarche, the postpartum period [6] and after first pregnancy [7] . In a case-controlled study, birth of a live
child was the only life event that was reported significantly more often by patients with OCD compared
with control subjects [8] .
The literature on the role of reproductive events on
the course of psychiatric illness has focused primarily
on maternity blues, postpartum depression and postpartum psychosis, however, there is increasing awareness that periods of hormonal change are also associated
with the development or triggering of OCD. DSM-5
allows the use of the ‘with peripartum onset’ specifier
to characterize episodes of major depressive disorder
and bipolar disorder but there is acknowledgement in
the text that “onset or exacerbation of OCD, as well as
symptoms that can interfere with the mother–infant
relationship (for example, aggressive obsessions leading
to avoidance of the infant) have been reported in the
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postpartum period” [1] . Some authors question as to
whether OCD is more common in the postpartum
period compared with other times in a woman’s life;
however, there is support for postpartum OCD’s
unique diagnostic status due to its distinct symptom
profile and illness course [9] .
Due to the general lack of awareness among clinicians as well as patients of the relationship between
OCD and childbirth the disorder may be underdiagnosed or misdiagnosed as major depressive disorder.
This article discusses the prevalence, clinical features
and common psychiatric comorbidities followed by
a discussion of diagnostic considerations, differential
diagnosis and consequences of underdiagnosis or misdiagnosis. Finally, the areas in need of further research
are proposed.
Prevalence
Both syndromal and subsyndromal symptoms of
OCD are common after childbirth. The prevalence
estimates of postpartum OCD vary depending on the
study population, screening/diagnostic instruments
used and the duration of the postpartum period [10] . A
meta-analysis of seven studies of OCD in postpartum
(up to 12 months) women using structured diagnostic interviews reported a prevalence of 2.43% [11] . An
exploratory analysis of regionally matched risk ratios
revealed postpartum women to be at greater risk of
experiencing OCD compared with the general female
population.
A recent prospective cohort study of 461 women estimated the prevalence of obsessive–compulsive symptoms to be 11% at 2 weeks postpartum, and almost
half of these women had persistence of symptoms
at 6 months postpartum [12] . Two prospective studies
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demonstrated that 1.7–4.0% of women had first onset
of OCD after childbirth. Women with a history of
OCD or perinatal OCD are also at risk for recurrence of
OCD in the postpartum period with studies reporting
rates of recurrence of 25 to 75% after childbirth [10,13] .
Clinical features & risk factors
The postpartum onset of OCD has generally
been described as appearance of symptoms within
12–26 weeks postpartum [12,14,15] , but some women
have a rapid onset (within days) after delivery.
Although the clinical presentation of postpartum
OCD varies widely, obsessions often include concerns
about intentionally or accidentally causing harm to the
baby, worrying about the baby dying while asleep, worrying about being criticized and/or judged as a mother,
cleanliness, symmetry/exactness or aggression [12,16–18].
Common compulsions include repetitive and ritualistic washing, checking, avoidance, concealment and
seeking reassurance [8,15,18,19] . Obsessions are usually
more frequent than compulsions [20] . A large number
of women (45%) who have obsessions and compulsions
at 2 weeks report persistence of symptoms at 6 months
postpartum [12,15,20] .
Postpartum OCD affects quality of life as mothers try to cope with significant levels of anxiety and
feelings of guilt for having to spend large amounts of
time dealing with obsessions and compulsions. Consequently, they may be less available to their children
physically and emotionally [21] ; however, the impact
of postpartum OCD on the neurodevelopment of the
child is unknown. The disorder also affects the relationships as family members may find it difficult to
cope with the disorder for having to engage in compulsive rituals themselves or due to the need to provide
constant reassurance.
Risk factors for postpartum OCD include primiparity, early postpartum period (first 4 weeks), personal
history of depression, obsessive–compulsive personality disorder, avoidant personality disorder and the
presence of OCD-related dysfunctional beliefs [10] . In
one study OCD was more frequent in mothers with
a personal history of previous psychiatric disorder,
somatic disease (when psychiatric symptoms present as
physical ailments) or obstetric complication in pregnancy or delivery [10] . Interestingly, women with postpartum OCD are more likely to have family histories
of mood disorders and substance use disorders rather
than OCD [15] .
Comorbidities
Psychiatric comorbidity appears to be the rule rather
than exception in women with postpartum OCD.
Approximately 27.5% of women have an anxiety dis-
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order and 70.6% of women have a comorbid depressive disorder [12] . Comorbidity with depression is
associated with chronicity and a poor prognosis of
the disorder [22] . In a small case series, approximately
20% of women had a comorbid diagnosis of bipolar
disorder [15] .
Diagnostic considerations
Identification of postpartum OCD and its differentiation from commonly occurring postpartum psychiatric disorders can be challenging for several reasons. First, OCD symptoms may not be recognized
by women as being abnormal, or feelings of shame
and guilt may prevent women from disclosing the
symptoms to their families or their caregivers. Second, women with obsessive thoughts of harming the
newborn may be reluctant to share these symptoms
with caregivers for fear of being reported to the Child
Protection Services, or having the children removed
from their care. And third, due to the general lack of
awareness of postpartum OCD, clinicians may fail to
elicit information about obsessions and compulsions.
Due to their increased risk of developing OCD,
women with prior histories of depression, anxiety
disorders or OCD should be identified as soon as
possible during pregnancy and followed closely in
regards to emergence of obsessions or compulsions.
Similarly, women with depression or anxiety disorders in the postpartum period should be screened for
obsessive–compulsive symptoms. A couple of simple
screening questions are: “do you have unpleasant
thoughts, urges or images that repeatedly enter your
mind?” and “do you feel driven to perform certain
behaviors or mental acts over and over again?” [1] .
Those who respond positively to one or both the
questions should be assessed for OCD using the
DSM-5 diagnostic criteria. The degree of insight into
the beliefs that underlie the obsessions and compulsions should be evaluated. The DSM-5 differentiates
between good/fair insight (recognizing the beliefs
are definitely or probably not true, or showing doubt
of their actuality), poor insight (thought that beliefs
are likely true) or absent insight/delusional beliefs
(thought that beliefs are definitely true) [1] ). Due to
their diagnostic and clinical implications, delusional
beliefs accompanying OCD should be identified. For
all women with postpartum OCD, especially, those
with comorbid depression, or anxiety, the risk of
self-harm should be assessed. Assessment should also
include the impact of symptoms on the functioning
and quality of life of patients and their close family
members.
The Yale-Brown Obsessive Compulsive Scale
(Y-BOCS) is the most commonly used scale to evaluate
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Box 2. Differential diagnosis of postpartum
obsessive–compulsive disorder.
• Normal obsessions and compulsions in the
postpartum period
• Generalized anxiety disorder
• Major depressive disorder with obsessions and
compulsions
• Bipolar depression with obsessions and
compulsions
• Postpartum psychosis

the severity of symptoms and to monitor response to
treatment [23,24] however, it has not been validated in
women with postpartum OCD. The Y-BOCS has 37
items that assess obsessive symptoms and 21 items that
assess compulsive symptoms. Items are scored from 0
to 4 with 0 indicating no symptoms and 4 indicating
severe symptoms. Thus the total score can range from
0 to 40. Scores of 1–7, 8–15, 16–23, 24–32 and 33–40
are considered subclinical, mild, moderate, severe and
extremely severe symptoms, respectively. Response to
treatment is usually defined as a 25–35% or greater
decrease in a Y-BOCS score, and a score of 8 or less on
the Y-BOCS indicates remission for OCD. This usually translates into full functionality, no or minimal
anxiety [25] and depressive symptoms; thus, the individual no longer meets the diagnostic criteria for the
disorder.
The Perinatal Obsessive Compulsive Scale
(POCS) is the only scale that was developed and
validated in women with perinatal OCD [26] . POCS
is self-report questionnaire with a prenatal and a
postpartum version. The postpartum version has 19
items on thoughts and 14 items on behaviors. Each
symptom is assessed on a severity scale and an interference scale. The receiver operating characteristic
analysis demonstrated that a score of 9 on the severity scale had a sensitivity of 64% and a specificity of
95% with an area under the curve of 0.183. In comparison, a score of 7 on the Y-BOCS had a sensitivity
of 55% and a specificity of 90% with an area under
the curve of 0.753.
The Edinburgh Postnatal Depression Scale [27] and
the State-Trait Anxiety Inventory [28] can be used to
identify and monitor the accompanying symptoms
of depression and anxiety, respectively. Women with
comorbid depression should be further evaluated to
determine whether the depressive episode is related
to major depressive disorder or bipolar disorder.
Differential diagnosis
Box 2 lists the differential diagnosis of postpartum
OCD. Symptoms of OCD should be differentiated
from normal thoughts that preoccupy parents about
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their child’s safety and are considered a ‘normal’ feature of parenthood, occurring in 34–65% of women
after delivery [29] . Due to their adaptive nature, preoccupying thoughts about child safety may be helpful
in protecting the infant from potential harm. These
‘normal’ preoccupying thoughts are usually temporary and do not interfere with normal daily functioning or appropriate childcare responsibilities. In contrast, the obsessions and complusions of postpartum
OCD are clearly maladaptive and time consuming,
causing distress or functional impairment [1] .
Postpartum OCD should be distinguished from
other psychiatric disorders accompanying childbirth
including anxiety, depression or psychosis. Due to
the overlap of anxiety symptoms and avoidant behavior in the two disorders, postpartum OCD should
be differentiated from generalized anxiety disorder
(GAD). GAD is characterized by difficulty controlling apprehensive worry about events and circumstances (such as work or school performance)
occurring more often than not over the course of
6 months [1] . The focus of the worry in GAD usually
involves concerns related to day-to-day activities and
routine life circumstances whereas the obsessions of
OCD generally do not involve concerns about dayto-day activities [3] . While there are no studies on the
topic, misdiagnosis of OCD as depression may not
be uncommon. Obsessional thoughts about harming the infant are not unique to postpartum OCD
and have been reported in over 57% of women with
postpartum depression [17] . The ruminations in postpartum depression are usually mood-congruent and
are not intrusive or distressing as is the case in postpartum OCD [29] . However, postpartum depression
(major depressive disorder or bipolar disorder) can
co-occur with OCD and should be diagnosed as a
comorbid disorder. Use of screening instruments for
postpartum depression like EPDS may be helpful in
differentiating these disorders.
Postpartum OCD characterized by obsessive
thoughts of harm to the infant should be carefully
differentiated from postpartum psychosis. Women
with postpartum OCD are generally aware of the
unreasonable, unwanted and ego-dystonic nature
of their thoughts and experience tremendous anxiety about having the obsessive symptoms. The differentiation of postpartum OCD characterized
by absence of insight or delusional beliefs from
other types of postpartum psychosis is particularly challenging [30] . Postpartum psychosis is usually considered a manifestation of bipolar disorder
and is accompanied by symptoms of hyperactivity, decreased sleep requirement, flight of ideas,
increased goal-directed activities, reckless behavior,
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delusions and hallucinations [31] . Women with postpartum OCD are more likely to have a history of
obsessions or compulsions prior to the development
of delusional beliefs. A personal or a family history
of bipolar disorder is more likely to be encountered
in women with postpartum psychosis than postpartum OCD. Postpartum psychosis is a psychiatric emergency that typically requires treatment in
an inpatient setting due to concerns regarding the
safety of the mother and her newborn. Women with
postpartum OCD, on the other hand, tend to take
tremendous precautions to prevent doing harm to
their infant [29] .
Treatment
In general, treatment of postpartum OCD can be
carried out in outpatient settings. Hospital treatment may be indicated for women who are at risk
for suicide, are unable to provide adequate selfcare, have a co-occurring psychiatric disorder that
requires hospital treatment such as severe depression
or bipolar disorder [32] . Pharmacological and psychotherapeutic treatments can be used on their own or
in combination or women with postpartum OCD.
Severity of the symptoms, as well as patient preference, should be taken into account when choosing a
treatment modality. The literature on both treatment
modalities is discussed below.
Pharmacological treatment
Surprisingly, there are no controlled trials of drugs
in the acute or preventative treatment of postpartum OCD [33] . The selection of treatment modality
should depend on the nature and severity of OCD
symptoms, type and severity of comorbid psychiatric
disorder, co-occurring medical conditions, availability of cognitive behavior therapy (CBT) and previous treatment response [34] . CBT is a good option
for women who are breastfeeding, are not interested
in drug treatment, and have both obsessions and
compulsions [35] .
Pharmacotherapy may be the preferred option
for patients who have more severe obsessions, as is
usually the case in postpartum OCD. Similar to the
treatment of nonchildbirth-related OCD, selective
serotonin reuptake inhibitors (SSRIs) are the pharmacological treatment of choice for most patients
with postpartum OCD [34] . The extant literature on
the pharmacotherapy of postpartum OCD includes
only open-label studies. In one case series two of three
patients treated with fluvoxamine showed a positive
response, defined as a 30% or greater decrease in
the total Y-BOCS score [15] . In a case series by Sichel
and colleagues, 15 patients treated with fluoxetine,
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clomipramine, desipramine or a combination of these
drugs showed significant responsiveness to these
SSRIs [20] . In each case, scores on the Clinical Global
Improvement scale improved following 12 weeks of
treatment and the improvement was maintained with
continued treatment over a 1-year period.
Misri and Mills evaluated the effectiveness of
quetiapine as an augmenting agent for SSRIs (paroxetine, fluoxetine and sertraline) and serotonin norepinephrine reuptake inhibitors (SNRIs: venlaxfine)
in treatment-resistant postpartum OCD [36] . Treatment resistance was defined by Mirsi and Mills as no
response to at least 8 weeks of SSRI or SNRI monotherapy. Out of the 17 women treated with quetiapine, 14 completed the 12 weeks of treatment and three
dropped out due to side effects, mainly sedation. The
11 women who responded to quetiapine augmentation had a mean reduction of 59.6% in the Y-BOCS
scores with a mean dose of 112.5 mg daily. There
are no data on the duration of treatment for women
who have first onset of OCD in the postpartum
period. For OCD in general, it is recommended that
pharmacological treatment should be continued for
1–2 years before considering a gradual taper by decrements of 10% –25% every 1–2 months with close
monitoring for symptom return or exacerbation [34] .
Treatment of OCD with comorbid bipolar disorder
is challenging due to the risk of induction of mania
with the use of antidepressants [37,38] . Thus pharmacological treatment if indicated should be carried out
with mood stabilizers alone or in combination with
atypical antipsychotic drugs [38] .
Medications & breastfeeding
Most antidepressants are excreted in low concentrations in breast milk and only a few reach the level
considered unsafe for the infant (>10% of the maternal weight-adjusted dose in breast milk) [39] . Nursing
mothers should be informed that the infant will be
exposed to medications and may have adverse events
such as irritability, decreased feeding and sleep problems [40,41] . There is little evidence that there are
any serious adverse effects in infants but long-term
neurodevelopmental effects have not been adequately
studied.
Psychotherapeutic treatment
Cognitive behavior therapy

Controlled trials support the effectiveness of CBT
including exposure response prevention (ERP) in
OCD [42,43] , but there are no controlled studies of its
use in women with postpartum OCD [44] . In ERP,
patients are taught to confront feared situations and
objects (for example, exposure) and to refrain from
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performing rituals (i.e., response prevention) [34] . In
one study, six cases of postpartum OCD were treated
using CBT delivered over a 2-week period. All mothers
improved on self-report and clinician-rated measures
and the improvement was sustained at 3–5-month
follow-up. The number of treatment sessions, their
length and the duration of an adequate trial have not
been established for postpartum OCD but in general
13–20 weekly sessions are recommended for most
patients [45] . Successful CBT should be followed by
monthly booster sessions for 3–6 months to sustain
the improvement [34] . It is important to note that
although psychotherapeutic treatment for depression,
anxiety and OCD is generally the same, the focus of
CBT will change in accordance with the nuances of
the patients’ diagnoses.
Misri and colleagues studied the effect of addition
of CBT to paroxetine in women with postpartum
depression and comorbid anxiety disorders including
OCD [46] . Both paroxetine monotherapy and combination therapy were effective in reducing depression
and anxiety symptoms; however, there were no additional benefits from combining the two treatment
modalities.
Psychoeducation

Psychoeducation should be an integral part of the
treatment plan [23] . The focus of psychoeducation
should be on imparting information about the disorder and psychiatric comorbidities, reducing feelings
of blame and guilt, providing a rationale for treatment and promoting treatment adherence [32] . Incorporating a cognitive-behavioral prevention program
into childbirth education classes also appears effective in reducing the obsessive–compulsive symptoms
in the postpartum period [34,47] . Family members
may also benefit from education about the disorder
and its impact of family functioning.
Revisiting clinical vignettes

The clinical vignettes illustrate some of the challenges
clinicians commonly face in diagnosing OCD and its
differentiation from other postpartum psychiatric disorders. ‘Ms A’ was diagnosed with OCD with good
to fair insight. Following a discussion of her diagnosis
and treatment options, she agreed to a retrial of fluvoxamine 150 mg daily. Due to a partial response after
4 weeks, the dose was optimized over a 4-week period
to 300 mg. She noted an improvement in OCD symptoms as demonstrated by a reduction in the Y-BOCS
score from 35 to 7 over a 3-month period.
’Ms B’ was given the DSM-5 diagnosis of OCD
with absent insight/delusional beliefs due to the history of obsessions and compulsions before she devel-
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oped delusional beliefs. Moreover, the delusional
beliefs were linked to her obsessive thoughts. The
absence of symptoms such as hallucinations and
formal thought disturbance ruled out a diagnosis of
schizophrenia or schizoaffective disorder. The lack of
accompanying mood changes and absence of features
such as sleep loss, confusion and agitation ruled out a
diagnosis of postpartum psychosis. Due to the onset
of psychotic symptoms after delivery, a differential
diagnosis of bipolar I disorder was considered; however, there were no current or past symptoms suggestive of mania or depression. She was treated successfully with sertraline 200 mg and risperidone 3 mg
daily. Six months following initiation of treatment
she realized that she had falsely accused her father
and apologized to him for making false allegations.
Summary & recommendation
The traditional view that postpartum psychiatric
disturbance includes only the baby blues, postpartum depression and puerperal psychosis ignores the
clinical reality that childbirth can be associated
with a wide range of psychiatric disorders including
OCD. Despite the divergent findings of studies on
the prevalence of postpartum OCD, childbirth can
clearly trigger or exacerbate OCD. Women considered at risk for developing OCD should be informed
of this risk and screened for obsessions and compulsions during and after pregnancy. Those with a
positive screen should have a diagnostic evaluation
performed to establish a diagnosis of OCD and any
comorbid psychiatric disorder(s). Although the clinical presentation of postpartum OCD varies widely,
a common theme of obsessions and compulsions
revolves around causing harm to the newborn or
about its safety. Obsessions appear to be more common than the compulsions. Despite its common
occurrence OCD appears to be frequently underdiagnosed or misdiagnosed. Contributing factors to
the underdiagnosis or misdiagnosis include a general
lack of awareness of its existence among healthcare
providers, patients and caregivers, frequent comorbidity with major depressive disorder and patients’
reluctance to seek professional help. Failure to diagnose the disorder correctly is associated with potentially serious consequences for the patient and her
family. Clinical vigilance and detailed evaluation
are essential to ensure that OCD is not missed, or
misdiagnosed as another psychiatric disorder. In the
absence of good quality data, treatment of postpartum OCD should follow the same guidelines as the
treatment of nonpostpartum OCD. Factors such as
severity of OCD symptoms, nature and severity of
comorbid psychiatric disorder(s) if any, safety issues,
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patient preference and compatibility with breastfeeding should guide the treatment choice. In general,
patients with OCD require higher doses of SSRIs
compared with the dose of antidepressants required
to treat major depressive disorder. Before considering
augmentation, it is important to ensure that patients

Review

receive an adequate therapeutic trial, both in terms
of dose and duration, of an SSRI. Due to the high
risk of recurrence, pregnant women with a history of
postpartum OCD should be offered the prophylactic use of an antidepressant or a psychotherapeutic
treatment such as CBT.

Executive summary
Background
• The literature on the role of reproductive events on the course of psychiatric illness has focused primarily on
maternity blues, postpartum depression and postpartum psychosis; however, there is increasing awareness
that periods of hormonal change are also associated with the triggering or recurrence of obsessive–
compulsive disorder (OCD).
• Due to the general lack of awareness among clinicians as well as patients of the relationship between OCD
and childbirth the disorder may be underdiagnosed or misdiagnosed as major depressive disorder.

Prevalence
• Studies show a range from 1.7 to 4.0% of women having their first onset of OCD after childbirth.
• Women with a history of OCD or perinatal OCD are also at risk for recurrence of OCD in the postpartum
period with studies reporting rates of recurrence of 25–75% after childbirth.

Clinical features & risk factors
• The postpartum onset of OCD has generally been described as appearance of symptoms within 12–26 weeks
postpartum, but some women have a rapid onset (within days) after delivery.
• Risk factors for postpartum OCD include primiparity, early postpartum period, personal history of depression,
obsessive–compulsive personality disorder, avoidant personality disorder and the presence of OCD-related
dysfunctional beliefs.

Comorbidity
• Approximately 27.5% of women have an anxiety disorder and 70.6% of women have a comorbid depressive
disorder.

Diagnostic considerations
• Diagnosis may be impacted by mothers’ reluctance to share obsessions and compulsions, and their lack of
recognition between normal childcare preoccupations and obsessions.
• Use of a screening instrument, such as the Perinatal Obsessive Compulsive Scale, can be helpful for diagnosis.

Differential diagnosis
• For all women with postpartum OCD, especially those with comorbid depression, the risk of self-harm should
be assessed.
• Due to the overlap of anxiety symptoms and avoidant behavior in the two disorders, postpartum OCD should
be differentiated from generalized anxiety disorder.
• OCD can be accompanied by the absence of insights into the obsessive beliefs, and therefore it is important to
differentiate it from postpartum psychosis.

Treatment
• Psychopharmacology and psychotherapy can both be useful in the treatment of postpartum OCD together or
separately.
• Comorbidities should be considered when treating with medication, particularly mood disorders.
• Psychoeducation can benefit both the mother and family to impart information about the disorder and
psychiatric comorbidities, reduce feelings of blame and guilt, provide rationale for treatment and promote
treatment adherence.

Summary & recommendation
• Women considered at risk for developing OCD should be informed of this risk and screened for obsessions and
compulsions during and after pregnancy.
• Treatment of postpartum OCD should follow the same guidelines as the treatment of nonpostpartum OCD.
• Breastfeeding is an important consideration in the treatment of postpartum OCD.
• Due to the high risk of recurrence, pregnant women with a history of postpartum OCD should be offered the
prophylactic use of an antidepressant or a psychotherapeutic treatment such as CBT.

Future perspective
• Further studies are needed on the use of screening instruments designed specifically for use in women with
postpartum OCD.
• Research to guide treatment of OCD with comorbid disorders in the postpartum period is urgently needed.
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Future perspective
There is a surprising paucity of studies on the prevalence, clinical features, comorbid patterns, illness
course, etiology, detection and treatment of postpartum OCD. Prevalence studies should focus on
both syndromal as well as subsyndromal OCD at
different time periods (e.g., 1 month, 3 months and
6 months). Rather than focusing on only postpartum OCD, studies of populations with common
comorbid disorders (mood and anxiety) are urgently
needed. There are no studies on the clinical correlates, comorbid patterns, family history and treatment response in early-onset (say with onset during the first 2–4 weeks after birth) versus late-onset
postpartum OCD. This is an important area of
inquiry because there is emerging evidence that early
onset of psychiatric illness in some women may be a
manifestation of bipolar disorder [48,49] .
Further studies are needed on the use of screening
instruments designed specifically for use in women
with postpartum OCD. There are no controlled

studies on the psychotherapeutic or pharmacological
treatment of postpartum OCD occurring alone or in
combination with postpartum depression. There is
absolutely no guidance in the literature on the treatment of this disorder with comorbid bipolar disorder. And finally, the potent role of childbirth including primiparity needs to be elucidated for a better
understanding of not only OCD but postpartum
psychiatric disorders in general.
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